Robert E Landry Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert E Landry.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Robert E Landry for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 555.67 | 5,000 | 2,778,350 | 5,000 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 3,500 | 1,398,810 | 25,000 | |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 658.00 | 3 | 1,974 | 24,669 | 24.7 K to 24.7 K (-0.01 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 647.50 | 388 | 251,230 | 24,672 | 25.1 K to 24.7 K (-1.55 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 4,611 | 3,022,833 | 25,060 | 29.7 K to 25.1 K (-15.54 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 555.67 | 5,000 | 2,778,350 | 29,671 | 24.7 K to 29.7 K (+20.27 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 655.57 | 2,802 | 1,836,907 | 24,671 | 27.5 K to 24.7 K (-10.20 %) |
| Jul 22 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 3,500 | 1,398,810 | 27,473 | 24 K to 27.5 K (+14.60 %) |
| Jul 14 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 640.50 | 579 | 370,850 | 23,973 | 24.6 K to 24 K (-2.36 %) |
| Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 3,000 | 1,198,980 | 28,500 | |
| Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 642.46 | 2,421 | 1,555,396 | 24,552 | 27 K to 24.6 K (-8.98 %) |
| Jul 13 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 3,000 | 1,198,980 | 26,973 | 24 K to 27 K (+12.51 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 555.67 | 10,000 | 5,556,700 | 10,000 | |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 399.66 | 2,500 | 999,150 | 31,500 | |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 650.41 | 3 | 1,951 | 23,973 | 24 K to 24 K (-0.01 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 648.54 | 94 | 60,963 | 23,976 | 24.1 K to 24 K (-0.39 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 646.18 | 37 | 23,909 | 24,070 | 24.1 K to 24.1 K (-0.15 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 645.99 | 57 | 36,821 | 24,107 | 24.2 K to 24.1 K (-0.24 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 643.84 | 104 | 66,959 | 24,164 | 24.3 K to 24.2 K (-0.43 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 642.93 | 48 | 30,861 | 24,268 | 24.3 K to 24.3 K (-0.20 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 640.32 | 43 | 27,534 | 24,316 | 24.4 K to 24.3 K (-0.18 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 639.88 | 80 | 51,190 | 24,359 | 24.4 K to 24.4 K (-0.33 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 638.99 | 45 | 28,755 | 24,439 | 24.5 K to 24.4 K (-0.18 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 637.40 | 40 | 25,496 | 24,484 | 24.5 K to 24.5 K (-0.16 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 636.50 | 585 | 372,353 | 24,524 | 25.1 K to 24.5 K (-2.33 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 634.14 | 24 | 15,219 | 25,109 | 25.1 K to 25.1 K (-0.10 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 640.88 | 2,019 | 1,293,937 | 25,133 | 27.2 K to 25.1 K (-7.44 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 399.66 | 2,500 | 999,150 | 27,152 | 24.7 K to 27.2 K (+10.14 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 640.88 | 9,321 | 5,973,642 | 24,652 | 34 K to 24.7 K (-27.44 %) |
| Jul 09 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 555.67 | 10,000 | 5,556,700 | 33,973 | 24 K to 34 K (+41.71 %) |